Information from Industry- Sponsored Supplement

Advancing Maternal-Fetal Immunology by Unlocking New Insights into Immune Pathways

This promotional article was developed in conjunction with and sponsored by The Janssen Pharmaceutical Companies of Johnson & Johnson.


In this supplement to OBGM, Neely Mozaffarian discusses how immunology researchers anticipate both improving the therapy for HDFN as well as developing diagnostic tests to identify women for whom HDFN might be an issue.

Click here to read more 

Next Article: